The global Insulin Delivery Device Market, valued at US$32.6 billion in 2024 stood at US$35.3 billion in 2025 and is ...

Houston’s Axiom Space launched its fourth human spaceflight mission on Wednesday. One of the mission’s experiments hopes to ...

US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro, its widely used diabetes and weight-loss ...

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.

Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

Patient satisfaction. More patients in the insulin pen group (77.1%) dialed at least one dose of insulin using the pen device, compared with 5% of patients who drew at least one dose using the ...

The authors found that diabetes-related and overall medication adherence were comparable for patients initiating insulin with a pen versus a vial and syringe (53% versus 50% and 94% versus 94% ...

India’s drug regulator has given the nod to Eli Lilly’s once-a- week Mounjaro (tirzepatide) injection in the KwikPen format, ...

India’s drug regulator has approved Eli Lilly and Company’s diabetes and obesity drug Mounjaro in a KwikPen presentation, the ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

NovoLog (insulin aspart) is a fast-acting insulin used for diabetes treatment. It’s injected 5 to 10 minutes before meals. It may be prescribed with other insulins or oral diabetes drugs.